Skip to main content
padlock icon - secure page this page is secure

Combining Classifiers for HIV-1 Drug Resistance Prediction

Buy Article:

$68.00 + tax (Refund Policy)

This paper applies and studies the behavior of three learning algorithms, i.e. the Support Vector machine (SVM), the Radial Basis Function Network (the RBF network), and k-Nearest Neighbor (k-NN) for predicting HIV-1 drug resistance from genotype data. In addition, a new algorithm for classifier combination is proposed. The results of comparing the predictive performance of three learning algorithms show that, SVM yields the highest average accuracy, the RBF network gives the highest sensitivity, and k-NN yields the best in specificity. Finally, the comparison of the predictive performance of the composite classifier with three learning algorithms demonstrates that the proposed composite classifier provides the highest average accuracy.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: HIV-1 drug resistance prediction; SVM; combining classifiers; composite classifier; k-NN; the RBF network

Document Type: Research Article

Publication date: June 1, 2008

More about this publication?
  • Protein & Peptide Letters publishes short papers in all important aspects of protein and peptide research, including structural studies, recombinant expression, function, synthesis, enzymology, immunology, molecular modeling, drug design etc. Manuscripts must have a significant element of novelty, timeliness and urgency that merit rapid publication. Reports of crystallisation, and preliminary structure determinations of biologically important proteins are acceptable. Purely theoretical papers are also acceptable provided they provide new insight into the principles of protein/peptide structure and function.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more